/
OM
$4.33-$0.25 (-5.46%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$84.9M
19M shares
52-week range
$3.00 – $21.36
7% from low
Sector
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Exchange
NASDAQ
CS
Borrow rate
0.47%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-745.37
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.0M | $15.1M | $49.9M | $102.6M | $115.4M | $130.4M | $113.7M | $119.5M |
| Cost of revenue | $8.1M | $32.9M | $63.0M | $95.0M | $97.5M | $101.4M | $75.1M | $72.7M |
| Gross profit | −$6.1M | −$17.8M | −$13.0M | $7.6M | $17.8M | $29.0M | $38.6M | $46.8M |
| Gross margin | -304.7% | -118.1% | -26.1% | 7.4% | 15.5% | 22.2% | 33.9% | 39.1% |
| R&D | $22.9M | $23.3M | $28.9M | $36.7M | $48.9M | $57.3M | $38.4M | $21.2M |
| Operating income | −$46.6M | −$70.3M | −$117.5M | −$130.5M | −$161.0M | −$169.8M | −$113.4M | −$66.7M |
| EBITDA | −$43.6M | −$62.1M | −$114.8M | −$124.9M | −$152.8M | −$153.8M | −$97.9M | −$62.4M |
| Net income | −$49.8M | −$68.3M | −$121.5M | −$131.9M | −$163.0M | −$172.8M | −$128.0M | −$81.7M |
| Net margin | -2480.3% | -453.0% | -243.3% | -128.6% | -141.2% | -132.5% | -112.6% | -68.3% |
| EPS (diluted) | -1.65 | -34.06 | -2.83 | -43.41 | -50.75 | -52.27 | -36.95 | -5.37 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $127M | $-2.89 | $-2.92–$-2.86 | 2 |
| 2027 | $140M | $-2.18 | $-2.24–$-2.11 | 2 |
| 2028 | $155M | $-1.76 | $-1.78–$-1.75 | 1 |
| 2029 | $178M | $-1.13 | $-1.14–$-1.12 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
Outset Medical, Inc. Common Stock
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
www.outsetmedical.com- Employees
- 310
- IPO / List date
- Sep 15, 2020
- HQ
- SAN JOSE, CA
Held by traders on TradeandTell
No one on the platform currently holds OM.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 222,075 | $852.8K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2025-03-20 | 1-for-15reverse |
Recent trades on TradeandTell
No one on the platform has traded OM yet.
